Arvinas Inc (ARVN)

전일 마감가:

$32.48

열려 있는:

$33.12

하루 거래량:

612.61K

시가총액:

$2.22B

수익:

$78.50M

순이익/손실:

$-367.30M

주가수익비율:

-5.8014

EPS:

-5.59

순현금흐름:

$-350.70M

1주 성능:

+2.63%

1개월 성능:

-16.93%

6개월 성능:

+100.06%

1년 성능:

+29.93%

1일 변동 폭

$31.68

$33.15

52주 변동 폭

$13.57

$53.08

Arvinas Inc Stock (ARVN) Company Profile

명칭

Arvinas Inc

부문

Healthcare (1190)

산업

Biotechnology (681)

전화

203-535-1456

주소

5 Science Park, 395 Winchester Avenue, New Haven, CT

직원

77

트위터

@ArvinasInc

다음 수익 날짜

2024-05-29

최신 SEC 제출 서류

ARVN's Discussions on Twitter

Arvinas Inc Stock (ARVN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-02-14	다운그레이드	Citigroup	Buy → Neutral
2024-02-01	개시	Goldman	Buy
2023-12-19	업그레이드	Wells Fargo	Equal Weight → Overweight
2023-12-06	업그레이드	Jefferies	Hold → Buy
2023-11-20	업그레이드	Guggenheim	Neutral → Buy
2023-10-23	업그레이드	Wedbush	Neutral → Outperform
2023-06-26	재개	Oppenheimer	Outperform
2023-01-12	다운그레이드	Guggenheim	Buy → Neutral
2023-01-03	다운그레이드	Wells Fargo	Overweight → Equal Weight
2022-09-09	개시	Barclays	Overweight
2022-06-21	개시	Jefferies	Hold
2022-05-09	다운그레이드	Wedbush	Outperform → Neutral
2022-04-28	개시	Credit Suisse	Outperform
2022-04-06	개시	Morgan Stanley	Equal-Weight
2022-02-11	재개	BMO Capital Markets	Outperform
2022-02-10	개시	Wells Fargo	Overweight
2022-01-19	개시	Goldman	Buy
2021-12-07	개시	Cowen	Outperform
2021-10-14	개시	SVB Leerink	Outperform
2021-09-30	개시	Stifel	Buy
2021-09-09	개시	BofA Securities	Buy
2021-05-21	개시	UBS	Buy
2021-04-21	개시	Truist	Buy
2021-03-31	개시	BMO Capital Markets	Outperform
2020-12-14	업그레이드	Oppenheimer	Perform → Outperform
2020-06-01	업그레이드	Citigroup	Neutral → Buy
2020-05-12	개시	Oppenheimer	Perform
2019-12-19	개시	H.C. Wainwright	Buy
2019-11-25	개시	Guggenheim	Buy
2019-10-24	업그레이드	Goldman	Neutral → Buy
2019-09-25	개시	Wedbush	Outperform
2019-09-12	개시	BMO Capital Markets	Outperform
2019-08-06	개시	Cantor Fitzgerald	Overweight
2019-06-05	다운그레이드	Citigroup	Buy → Neutral
2019-04-12	개시	Evercore ISI	Outperform
2018-10-22	개시	Citigroup	Buy
2018-10-22	개시	Goldman	Neutral
2018-10-22	개시	Piper Jaffray	Overweight

모두보기

Arvinas Inc 주식(ARVN)의 최신 뉴스

Why Earnings Season Could Be Great for Arvinas (ARVN)

Zacks Investment Research

Arvinas (ARVN) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline

Zacks Investment Research

Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer

GlobeNewswire Inc.

Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised

Zacks Investment Research

Arvinas Inc (ARVN) 재무 분석

Arvinas Inc (ARVN) 매출 2024

Arvinas Inc (ARVN) 순이익 2024

Arvinas Inc (ARVN) 현금흐름 2024

Arvinas Inc (ARVN) 주당 순이익 2024